Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

[1]  S. Atkin,et al.  The immunohistochemical localisation of somatostatin receptors 1, 2, 3, and 5 in acoustic neuromas , 2004, Journal of Clinical Pathology.

[2]  S. Dudek,et al.  Mitogen-Activated Protein Kinases in Endothelial Pathophysiology , 2003, Journal of Investigative Medicine.

[3]  L. Deiana,et al.  PKC/Raf/MEK/ERK signaling pathway modulates native-LDL-induced E2F-1 gene expression and endothelial cell proliferation. , 2003, Cardiovascular research.

[4]  Q. Xue,et al.  Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts , 2003, Journal of Cancer Research and Clinical Oncology.

[5]  D. Noonan,et al.  Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. , 2003, Endocrinology.

[6]  S. Atkin,et al.  Fluvastatin Induces Apoptosis of Vascular Endothelial Cells: Blockade by Glucocorticoids , 2003, Cardiovascular surgery.

[7]  D. Barber,et al.  Somatostatin, Acting at Receptor Subtype 1, Inhibits Rho Activity, the Assembly of Actin Stress Fibers, and Cell Migration* , 2002, The Journal of Biological Chemistry.

[8]  M. Koizumi,et al.  Antiangiogenic Effect of Octreotide Inhibits the Growth of Human Rectal Neuroendocrine Carcinoma , 2002, Digestion.

[9]  L. Turnbull,et al.  Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours , 2002, British Journal of Cancer.

[10]  S. Atkin,et al.  Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle , 2002, Clinical endocrinology.

[11]  S. Lamberts,et al.  New somatostatin analogs: will they fulfil old promises? , 2002, European journal of endocrinology.

[12]  M. Hejna,et al.  The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  E. Woltering,et al.  Growing vascular endothelial cells express somatostatin subtype 2 receptors , 2001, British Journal of Cancer.

[14]  J. Laissue,et al.  Erratum to: Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands , 2001, European Journal of Nuclear Medicine.

[15]  S. Fox,et al.  Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. , 2001, The Lancet. Oncology.

[16]  P. Stork,et al.  Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2 , 2000, Journal of Physiology-Paris.

[17]  A. Buchan,et al.  Somatostatin receptor subtype expression and function in human vascular tissue. , 2000, American journal of physiology. Heart and circulatory physiology.

[18]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[19]  J. Rivier,et al.  Somatostatin receptor gene expression in neuroblastoma , 2000, Regulatory Peptides.

[20]  C. Rabourdin-Combe,et al.  sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes , 1999, Peptides.

[21]  S. Lamberts,et al.  Immunohistochemical localization of somatostatin receptor sst2A in human rheumatoid synovium. , 1999, The Journal of rheumatology.

[22]  D. Hoyer,et al.  [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. , 1998, European journal of pharmacology.

[23]  A. Schally,et al.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Basolo,et al.  Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  J. Laissue,et al.  Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. , 1996, Metabolism: clinical and experimental.

[26]  R. Danesi,et al.  The effects of the somatostatin analog octreotide on angiogenesis in vitro. , 1996, Metabolism: clinical and experimental.

[27]  M. Dichter,et al.  Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20 , 1996, Neuroscience.

[28]  G. Bell,et al.  Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Laissue,et al.  High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction? , 1994, International journal of cancer.

[30]  E. Woltering,et al.  Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. , 1991, The Journal of surgical research.

[31]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[32]  E. Woltering,et al.  Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action , 2004, Investigational New Drugs.

[33]  J. Laissue,et al.  Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands , 2001, European Journal of Nuclear Medicine.

[34]  L. Hofland,et al.  Somatostatin receptor subtype expression in human tumors. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  B. Wolffenbuttel,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society , 2000 .